Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 211

1.

[Efficacy of Short-Term Therapy With Meldonium in Patients With Chronic Heart Failure of Ischemic Etiology and Type 2 Diabetes Mellitus].

Statsenko S, Turkin SV, Fabritskaya SV, Shilina NN.

Kardiologiia. 2017 Apr;57(4):58-63. Russian.

PMID:
28762906
2.

Pharmacokinetics and pharmacodynamics of meldonium in exercised thoroughbred horses.

Knych HK, Stanley SD, McKemie DS, Arthur RM, Bondesson U, Hedeland M, Thevis M, Kass PH.

Drug Test Anal. 2017 May 16. doi: 10.1002/dta.2214. [Epub ahead of print]

PMID:
28513092
4.

The atypical excretion profile of meldonium: Comparison of urinary detection windows after single- and multiple-dose application in healthy volunteers.

Görgens C, Guddat S, Bosse C, Geyer H, Pop V, Schänzer W, Thevis M.

J Pharm Biomed Anal. 2017 May 10;138:175-179. doi: 10.1016/j.jpba.2017.02.011. Epub 2017 Feb 6.

PMID:
28213178
5.

Carnitine and γ-Butyrobetaine Stimulate Elimination of Meldonium due to Competition for OCTN2-mediated Transport.

Liepinsh E, Makarova E, Sevostjanovs E, Hartmane D, Cirule H, Zharkova-Malkova O, Grinberga S, Dambrova M.

Basic Clin Pharmacol Toxicol. 2017 May;120(5):450-456. doi: 10.1111/bcpt.12729. Epub 2017 Jan 10.

PMID:
27983775
6.

Outbreak in meldonium positive laboratory tests: are we missing something?

Panchaud A, Csajka C.

Br J Sports Med. 2016 Nov;50(22):1422-1423. doi: 10.1136/bjsports-2016-096253. Epub 2016 May 10. No abstract available.

PMID:
27166287
7.

Response to comment by Sergei V. Jargin: "Meldonium (Mildronate): primum nоn nocere".

Dambrova M, Liepinsh E.

Pharmacol Res. 2016 Dec;114:295-296. doi: 10.1016/j.phrs.2016.10.005. Epub 2016 Oct 8. No abstract available.

PMID:
27725311
8.

Meldonium (Mildronate): Primum nоn nocere.

Jargin SV.

Pharmacol Res. 2016 Dec;114:294. doi: 10.1016/j.phrs.2016.10.004. Epub 2016 Oct 8. No abstract available.

PMID:
27725310
9.

Rapid determination of meldonium in urine samples by capillary electrophoresis with capacitively coupled contactless conductivity detection.

Šlampová A, Kubáň P.

J Chromatogr A. 2016 Oct 14;1468:236-240. doi: 10.1016/j.chroma.2016.09.027. Epub 2016 Sep 13.

PMID:
27641719
10.

Story behind meldonium-from pharmacology to performance enhancement: a narrative review.

Schobersberger W, Dünnwald T, Gmeiner G, Blank C.

Br J Sports Med. 2017 Jan;51(1):22-25. doi: 10.1136/bjsports-2016-096357. Epub 2016 Jul 27. Review.

PMID:
27465696
11.

Meldonium and the Prohibited List.

Hughes D.

Aust Prescr. 2016 Jun;39(3):102. doi: 10.18773/austprescr.2016.032. Epub 2016 Apr 7. No abstract available.

12.

The unusual pharmacokinetics of meldonium: Implications for doping.

Liepinsh E, Dambrova M.

Pharmacol Res. 2016 Sep;111:100. doi: 10.1016/j.phrs.2016.05.029. Epub 2016 Jun 2. No abstract available.

PMID:
27262679
13.

A tennis lesson: sharp practice in the science behind the Sharapova case.

Arduini A, Zammit VA.

Postgrad Med J. 2016 Aug;92(1090):429-30. doi: 10.1136/postgradmedj-2016-134124. Epub 2016 Jun 1. No abstract available.

14.

Analyses of Meldonium (Mildronate) from Blood, Dried Blood Spots (DBS), and Urine Suggest Drug Incorporation into Erythrocytes.

Tretzel L, Görgens C, Geyer H, Thomas A, Dib J, Guddat S, Pop V, Schänzer W, Thevis M.

Int J Sports Med. 2016 Jun;37(6):500-2. doi: 10.1055/s-0036-1582317. Epub 2016 May 4. No abstract available.

15.

Meldonium (Mildronate): A Performance-Enhancing Drug?

Greenblatt HK, Greenblatt DJ.

Clin Pharmacol Drug Dev. 2016 May;5(3):167-9. doi: 10.1002/cpdd.264. Epub 2016 Apr 29. No abstract available.

PMID:
27128409
16.

Meldonium use by athletes at the Baku 2015 European Games.

Stuart M, Schneider C, Steinbach K.

Br J Sports Med. 2016 Jun;50(11):694-8. doi: 10.1136/bjsports-2015-095906. Epub 2016 Mar 25.

PMID:
27015859
17.

Sixty seconds on . . . meldonium.

Hawkes N.

BMJ. 2016 Mar 9;352:i1420. doi: 10.1136/bmj.i1420. No abstract available.

PMID:
26961537
18.

Pharmacological effects of meldonium: Biochemical mechanisms and biomarkers of cardiometabolic activity.

Dambrova M, Makrecka-Kuka M, Vilskersts R, Makarova E, Kuka J, Liepinsh E.

Pharmacol Res. 2016 Nov;113(Pt B):771-780. doi: 10.1016/j.phrs.2016.01.019. Epub 2016 Feb 2. Review.

PMID:
26850121
19.

[Effects of Meldonium in Early Postmyocardial Infarction Period].

Nechaeva GI, Zheltikova EN.

Kardiologiia. 2015;55(8):35-42. Russian.

PMID:
26761970
20.

Single- and Multiple-dose Pharmacokinetic, Safety and Tolerability Study of Mildronate Injection in Healthy Chinese Subjects Pharmacokinetic of Mildronate Injection.

Zhao Z, Chen J, Peng W, Wang X, Chen Z, Tang H, Liang Y, Ma Z, Chen J, Chen X, Zhong G, Huang M.

Drug Res (Stuttg). 2016 May;66(5):251-6. doi: 10.1055/s-0035-1569297. Epub 2015 Dec 23.

PMID:
26697890

Supplemental Content

Loading ...
Support Center